ANTHEM Share Price Today - Anthem Biosciences on NSE/BSE

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Anthem Biosciences	777.10	#1 43,650.78	#4 73.18	#1 2,124.33	#4 10.05	#1 583	#1 129.78	55.28
Advanced Enzyme Tech	375.15	4,198.93	25.03	745.76	11.31	176	69.66	63.24
CCME Global	116.90	529.00	-2,338.00	4.30	-	0	0.00	20.27
Vivo Bio Tech	26.80	59.47	#1 12.90	51.50	13.19	7	62.50	46.19
Shree Ganesh Bio-Tech	0.60	23.90	59.00	4.97	-79.63	0	77.78	45.10
Genomic Valley Biotech	26.67	8.10	-177.80	0.80	#1 300.00	0	-100.00	15.86

Quarterly Financials	Jun 2024	Sept 2024	Dec 2024	Mar 2025	Jun 2025	Sept 2025	Dec 2025	Mar 2026
Revenue	358	553	522	497	563	598	457	663
Expenses	218	330	338	288	349	332	291	344
EBITDA	140	223	184	209	214	266	165	319
Operating Profit %	36 %	37 %	32 %	40 %	35 %	40 %	31 %	44 %
Depreciation	19	20	20	30	27	34	35	40
Interest	4	4	3	1	2	3	0	2
Profit Before Tax	118	200	161	178	186	230	131	278
Tax	36	38	37	96	51	56	38	88
Net Profit	82	162	124	83	136	173	93	190
EPS in ₹	1.47	2.90	2.22	1.48	2.43	3.09	1.65	3.38

Balance Sheet	2020	2021	2022	2023	2024	2025	2026
Total Assets	787	1,034	1,619	2,015	2,398	2,808	3,429
Fixed Assets	306	361	329	449	483	705	1,048
Current Assets	403	616	1,098	1,323	1,482	1,737	1,803
Capital Work in Progress	50	19	154	164	345	297	264
Investments	99	209	273	499	472	433	125
Other Assets	333	445	863	903	1,099	1,373	0
Total Equity & Liabilities	787	1,034	1,619	2,015	2,398	2,808	3,429
Current Liabilities	247	285	223	164	339	326	326
Non Current Liabilities	118	47	41	110	135	72	61
Total Equity	422	702	1,355	1,741	1,925	2,410	3,043
Reserve & Surplus	414	693	1,346	1,627	1,813	2,298	2,930
Share Capital	8	9	9	114	112	112	112

Cash Flow	2020	2021	2022	2023	2024	2025
Net Cash Flow	9	18	308	-6	-159	133
Investing Activities	-109	-196	-205	-376	-222	-152
Operating Activities	166	278	333	306	140	418
Financing Activities	-48	-63	181	64	-77	-134

% Holding	Dec 2024	Jul 2025	Sept 2025	Dec 2025	Mar 2026
Promoter	77.23 %	76.88 %	74.69 %	74.69 %	74.68 %
FIIs	0.00 %	0.00 %	1.67 %	1.36 %	1.28 %
DIIs	0.00 %	0.00 %	7.22 %	7.60 %	11.55 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	0.00 %	0.00 %	9.61 %	9.60 %	9.38 %
Others	22.77 %	23.12 %	6.81 %	6.74 %	3.12 %
No of Share Holders	16	761	2,17,681	1,99,492	1,80,220

Record Date	Corporate Action	Information	Announcement Day	LTP at Annoucement	LTP at Record Day
22 Jul 2026	Annual General Meeting	NA	22 Jul 2026	789.95	769.10
26 Jun 2026	Dividend	₹ 2.00 /share	25 Jun 2026	789.95	769.10
13 Aug 2025	Quarterly Result Announcement	NA	13 Aug 2025	749.65	743.45
08 Nov 2025	Quarterly Result Announcement	NA	08 Nov 2025	742.15	697.00
05 Feb 2026	Quarterly Result Announcement	NA	05 Feb 2026	608.90	605.30
19 May 2026	Quarterly Result Announcement	NA	19 May 2026	784.20	789.95

Funding House	Current Holding %	1M Change	1M Change %	3M Change %
Tata Nifty Midcap 150 Index Fund Direct-Growth	0.12%	347	0.00%	0.12%
Edelweiss Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.04%	239	0.04%	0.04%
JioBlackRock Nifty Midcap 150 Index Fund Direct-Growth	0.12%	-167	0.00%	0.12%
Zerodha Nifty LargeMidcap250 Plus 8-13 Yr G-Sec 70:30 Index Fund Direct-Growth	0.04%	83	0.04%	0.04%
Kotak Nifty Midcap 150 Index Fund Direct-Growth	0.12%	71	0.01%	0.12%
Zerodha Nifty MidSmallcap400 50:50 Index Fund Direct-Growth	0.05%	48	0.05%	0.05%
Nippon India Nifty India Manufacturing Index Fund Direct-Growth	0.12%	28	0.00%	0.12%
DSP Nifty Midcap 150 Index Fund Direct-Growth	0.12%	22	0.00%	0.12%
Navi Nifty MidSmallcap 400 Index Fund Direct-Growth	0.08%	-21	-0.02%	0.08%
Groww Nifty Midcap 150 Index Fund Direct-Growth	0.12%	8	0.00%	0.12%
Motilal Oswal BSE 1000 Index Fund Direct-Growth	0.02%	7	0.00%	0.02%
DSP Nifty 500 Index Fund Direct-Growth	0.02%	3	0.00%	0.02%
Mahindra Manulife Equity Savings Fund Direct-Growth	0.45%	0	0.00%	0.05%
Mirae Asset Flexi Cap Fund Direct-Growth	1.12%	0	0.00%	0.10%
Axis Midcap Direct Plan-Growth	0.37%	0	0.00%	0.20%
Axis Nifty 500 Index Fund Direct-Growth	0.02%	0	0.00%	0.00%
Axis Small Cap Fund Direct-Growth	0.00%	0	0.00%	0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth	0.63%	0	0.00%	-0.13%
Bandhan BSE Healthcare Index Fund Direct-Growth	0.33%	0	0.00%	0.02%
Bandhan Innovation Fund Direct-Growth	0.00%	0	0.00%	-0.27%
Bandhan Midcap Fund Direct-Growth	0.70%	0	0.00%	0.01%
Bandhan Nifty Midcap 150 Index Fund Direct-Growth	0.13%	0	0.00%	0.01%
Bandhan Nifty Total Market Index Fund Direct-Growth	0.02%	0	0.00%	0.00%
Baroda BNP Paribas Nifty Midcap 150 Index Fund Direct-Growth	0.12%	0	0.00%	0.01%
Axis India Manufacturing Fund Direct-Growth	0.26%	0	0.00%	0.16%

About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104

Anthem Biosciences

Company News

Peer Comparison Compare Peers on Screener

Quarterly Financial Results

Balance Sheet

Cash Flow

Share Holding

Corporate Action

Announcements

Mutual Fund Holdings

Technical Indicators